Brief: Ault Global Holdings Inc Reports 6.15% Stake In Briacell Therapeutics Corp As Of August 6
Aug 9 (Reuters) - Briacell Therapeutics Corp BCT.V :
* AULT GLOBAL HOLDINGS INC REPORTS 6.15% STAKE IN BRIACELL
THERAPEUTICS CORP AS OF AUGUST 6 - SEC FILING
* AULT GLOBAL HOLDINGS INC PURCHASED BRIACELL THERAPEUTICS
SHARES
BASED ON BELIEF THAT SHARES, WHEN PURCHASED, WERE "UNDERVALUED"
Source text for Eikon: [https://bit.ly/3iupuVQ]
Further company coverage: BCT.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Briacell Therapeutics
See all newsBrief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
Brief: Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer
Brief: Briacell Expands Pipeline To Include An Ovarian Cancer Immunotherapy Candidate, Bria-Ova+™
Brief: Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients
Brief: Briacell Adds Nyu Langone Health’S Perlmutter Cancer Center As Clinical Site In Pivotal Phase 3 Breast Cancer Study